Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Gastrointestinal 1

Conditions

Resectable Pancreatic Cancer 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 213Irinotecan 146Leucovorin 140Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Bevacizumab 99Drug Therapy 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adjuvants, Immunologic × Gastrointestinal × Clear all
NCT04810910 2021-11-16

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Zhejiang Provincial People's Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡